Michel Herranz - Concepedia

Author

Michel Herranz

Spanish National Cancer Research Centre

Also Known As

M. D. Herranz, Michel Herranz

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Spanish National Cancer Research Centre Universidad Autónoma de Madrid Hospital Sant Joan de Déu Barcelona

About

Michel Herranz is an author at Spanish National Cancer Research Centre specializing in medicine, tumor biology, and epigenetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	946
2	Cell Biology	4	4	530
3	Pathology	2	2	125
4	Natural Sciences	1	1	30
5	Molecular Biology	1	1	291

Michel Herranz

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition Santiago Ropero, Mario F. Fraga, Esteban Ballestar, Nature Genetics Histone ModificationsChromatinChromatin RemodelingEpigenetic ChangeDeacetylase Inhibition	2006	291
Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer Rubén Agrelo, Wen‐Hsing Cheng, Fernando Setién, Proceedings of the National Academy of Sciences ChromatinWerner SyndromeOncogenic AgentEpigenetic ChangeGenetics	2006	262
A Mouse Skin Multistage Carcinogenesis Model Reflects the Aberrant DNA Methylation Patterns of Human Tumors Mario F. Fraga, Michel Herranz, Jesús Espada, Cancer Research	2004	214
CpG Island Hypermethylation of Tumor Suppressor Genes in Human Cancer Michel Herranz, Manel Esteller Medical intelligence unit Tumor BiologyCpg Island HypermethylationOncologyMedicineTumor Suppressor	2007	203
<i>EMP3</i>, a Myelin-Related Gene Located in the Critical 19q13.3 Region, Is Epigenetically Silenced and Exhibits Features of a Candidate Tumor Suppressor in Glioma and Neuroblastoma Miguel Alaminos, Verónica Dávalos, Santiago Ropero, Cancer Research	2005	159
Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells Santiago Ropero, Fernando Setién, Jesús Espada, Human Molecular Genetics	2004	93
The impact of MECP2 mutations in the expression patterns of Rett syndrome patients Esteban Ballestar, Santiago Ropero, Miguel Alaminos, Human Genetics Mendelian DisorderDisease MechanismGenetic DisorderGeneticsMecp2 Mutations	2004	72
The novel DNA methylation inhibitor zebularine is effective against the development of murine T-cell lymphoma Michel Herranz, Juan Martín-Caballero, Mario F. Fraga, Blood	2005	70
Adipose tissue mass is modulated by SLUG (SNAI2) Pedro A. Pérez–Mancera, Camino Bermejo‐Rodríguez, Inés González‐Herrero, Human Molecular Genetics	2007	67
Role of the BRAF Mutations in the Microsatellite Instability Genetic Pathway in Sporadic Colorectal Cancer M. L. Maestro, Marta Vidaurreta, María Teresa Sanz Casla, Annals of Surgical Oncology Genome InstabilitySomatic VariantMedicineGeneticsBraf Mutations	2006	53

Page 1